octreotide acetate (Ascil Biopharm)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameoctreotide acetate (Ascil Biopharm)
Drug Alias NameAPOC
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsDiarrheaHot FlashesAcromegaly +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesASCIL Biopharm
China Registration ClassN/A

Develop Information

Active CompaniesASCIL Biopharm
Inactive CompaniesN/A
Active IndicationsDiarrheaHot FlashesAcromegaly +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A